Weak Base Permeability Characteristics Influence the Intracellular Sequestration Site in the Multidrug-resistant Human Leukemic Cell Line HL-60*

A number of organelles contained within mammalian cells have been implicated in the selective sequestration of chemical entities including drug molecules. Specifically, weakly basic molecules have been shown to selectively associate with either the mitochondrial compartment or lysosomes; however, the structural basis for this differentiation has not been understood. To investigate this, we have identified a series of seven weakly basic compounds, all with pKa near neutrality, which have different sequestration sites within the multidrug-resistant HL-60 human leukemic cell line. Three of the compounds were selectively sequestered into the mitochondria of the cells, whereas the remainder were predominantly localized within lysosomes. Using specific chemical inhibitors to disrupt either mitochondrial or lysosomal accumulation capacity, we demonstrated that accumulation of these compounds into respective organelles are not competitive processes. Comparison of the permeability characteristics of these compounds as a function of pH revealed striking differences that correlate with the intracellular sequestration site. Only those compounds with significantly reduced permeability in the ionized state relative to the un-ionized state had the capacity to accumulate within lysosomes. Alternatively, those compounds with relatively pH-insensitive permeability selectively accumulated into mitochondria. Using novel quantitative assays for assaying drug accumulation into subcellular organelles, we demonstrated a correlation between these permeability characteristics and the lysosomal versus mitochondrial accumulation capacity of these compounds. Together, these results suggest that the selective accumulations of weakly basic compounds in either lysosomes and mitochondria occur via exclusive pathways governed by a unique permeability parameter.

[1]  S. Pond,et al.  Effects of lipophilicity and protein binding on the hepatocellular uptake and hepatic disposition of two anthracyclines, doxorubicin and iododoxorubicin , 1996, Cancer Chemotherapy and Pharmacology.

[2]  Y. Moriyama Membrane energization by proton pumps is important for compartmentalization of drugs and toxins: a new type of active transport. , 1996, The Journal of experimental biology.

[3]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[4]  D. Rickwood,et al.  Iodixanol: a nonionic iso-osmotic centrifugation medium for the formation of self-generated gradients. , 1994, Analytical biochemistry.

[5]  G. Capranico,et al.  Anthracyclines: selected new developments. , 2001, Current medicinal chemistry. Anti-cancer agents.

[6]  Richard P. Haugland,et al.  Handbook of fluorescent probes and research chemicals , 1996 .

[7]  C. Slapak,et al.  Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes. , 1997, Blood.

[8]  J. Modica-Napolitano,et al.  Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. , 2001, Advanced drug delivery reviews.

[9]  K. Mills,et al.  Application of magnetic chromatography to the isolation of lysosomes from fibroblasts of patients with lysosomal storage disorders , 1998, FEBS letters.

[10]  Sanford M. Simon,et al.  Intracellular pH and the control of multidrug resistance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  H. Girault,et al.  Charge and Delocalisation Effects on the Lipophilicity of Protonable Drugs , 1999 .

[12]  H. Rottenberg The measurement of membrane potential and deltapH in cells, organelles, and vesicles. , 1979, Methods in enzymology.

[13]  Muralikrishna Duvvuri,et al.  Separate Roles for the Golgi Apparatus and Lysosomes in the Sequestration of Drugs in the Multidrug-resistant Human Leukemic Cell Line HL-60* , 2003, Journal of Biological Chemistry.

[14]  Robin A. J. Smith,et al.  Delivery of bioactive molecules to mitochondria in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Simon,et al.  Defective Acidification in Human Breast Tumor Cells and Implications for Chemotherapy , 1998, The Journal of experimental medicine.

[16]  Muralikrishna Duvvuri,et al.  A Cell Fractionation Approach for the Quantitative Analysis of Subcellular Drug Disposition , 2004, Pharmaceutical Research.

[17]  V. Skulachev Uncoupling: new approaches to an old problem of bioenergetics. , 1998, Biochimica et biophysica acta.

[18]  P. Tulkens,et al.  Commentary. Lysosomotropic agents. , 1974, Biochemical pharmacology.